Kunal Merchant PhD

Kunal Merchant, PhD, has an extensive work experience in the field of clinical research and development. Kunal is currently a Clinical Scientist and Director at Celldex Therapeutics, where they collaborate with cross-functional teams and senior leadership to conduct immunology/allergy clinical programs. Prior to this, they worked as a Clinical Research Scientist at BioCryst Pharmaceuticals, providing scientific input and expertise to clinical trials for the berotrylstat program.

Before joining BioCryst Pharmaceuticals, Kunal worked as a Project Director at Covance and as a Senior Clinical Program Manager at Takeda, where they led and directed the execution of clinical studies in early clinical development programs. Kunal also served as a Global Program Leader at RRD International, LLC, a Clinical Program Director at UCB, and a Senior Manager of Clinical Sciences at United Therapeutics.

Kunal has a strong background in project management and implementation, as evidenced by their role as a Senior Project Manager/Project Leader at the Clinical Trials Transformation Initiative (CTTI). Kunal has also held positions at Salix Pharmaceuticals and GlaxoSmithKline, where they contributed to the development and management of clinical trials and programs.

Overall, Kunal Merchant, PhD, has demonstrated expertise in clinical research and development, with a focus on ensuring the quality and ethical conduct of clinical studies.

Kunal Merchant PhD began their education at St. Xavier's College, where they earned a Bachelor of Science degree in Physics from 1982 to 1985. Kunal then pursued further studies at the same institution and completed a Master of Science degree in Microbiology from 1985 to 1988. Following this, they attended Florida State University from 1988 to 1993, where they obtained a PhD in Molecular Biophysics.